William Blair research analyst Matt Larew was featured in MedCity News’ coverage of the acquisition of Abcam by the Danaher corporation.
The pricing for the acquired company as a result of an activist campaign was akin to “planting a flashing neon for-sale sign in the front yard,” Larew wrote in his note.